“Taffix® Nasal Powder Spray Forms an Effective Barrier Against Infectious New Variants of SARS-Cov-2 (Alpha, Beta and Delta)”. 2021. Archives of Clinical and Biomedical Research 5 (5): 794-802. https://fortunejournals.org/ojs/index.php/acbr/article/view/14869.